Le Lézard
Classified in: Health, Covid-19 virus
Subjects: HSP, AVO

Statement of the National Alliance for Hispanic Health on Historic Confirmation of Xavier Becerra as Nation's 25th Secretary of Health and Human Services


WASHINGTON, March 18, 2021 /PRNewswire/ -- "With Secretary Becerra, the nation has the leader of the U.S. Department of Health and Human Services, that it needs to meet the challenges of the COVID-19 pandemic and who will bring equity to our nation's health and human services to ensure all have the opportunity to achieve their full potential. We welcome this historic confirmation and look forward to working with Secretary Becerra to ensure the best health for all," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic health, the nation's leading Hispanic health advocacy group.

"Under his leadership, the Department of Health and Human Services (DHHS) will lead the COVID response in a way that recognizes the sacrifices and losses that so many have endured and create a new path forward. His decades of experience with government at all levels and legislative and regulatory processes have prepared him to be the DHHS Secretary that the country and indeed the global community needs. As the first Hispanic Secretary of Health and Human Services, his example will continue to be a beacon of achievement and possibility for all and especially for the next generation of Hispanic leadership," concluded Dr. Delgado.

About the National Alliance for Hispanic Health (The Alliance)
The Alliance is the nation's foremost science-based source of information and trusted advocate for the health of Hispanics in the United States with a mission to achieve the best health for all. For more information visit us at www.healthyamericas.org

SOURCE National Alliance for Hispanic Health


These press releases may also interest you

at 17:05
The global autism spectrum disorder therapeutics market size is estimated to grow by USD 766.1 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period. Increasing prevalence of...

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...



News published on and distributed by: